# Nuo Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 10-K/A
- Filed: 2023-04-18
- Accepted by EDGAR: Apr 18, 2023, 01:32 ET
- Period: 2022-12-31
- Accession: 0001437749-23-010489
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000143774923010489/aurx20230417_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000143774923010489/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000143774923010489/aurx20230417_10ka.htm

Filed Apr 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-010489. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.